Mitchell Blutt is a former executive partner with J.P. Morgan Partners and a recognized pioneer in the healthcare investment arena. The founder of Consonance Capital, Mitchell Blutt is experienced in recognizing and targeting investment opportunities in healthcare businesses.
Healthcare investments are among the most prominent in the US and are in large part driven by innovations in the medical industry. Some of the most exciting new developments that could be important investment opportunities include drone-delivered medical supplies. Drone deliveries are a technology being explored broadly, but they could mean significant improvements in the standard of care at hospitals and other treatment facilities.
Another big potential innovation in the coming years is a stem-cell treatment for diabetes. Although there are no approved therapies as of yet, work in this field has been ongoing for over a decade. The development of a device or therapy of this nature could be groundbreaking and has attracted the eye of many institutional investors.
Healthcare investments are among the most prominent in the US and are in large part driven by innovations in the medical industry. Some of the most exciting new developments that could be important investment opportunities include drone-delivered medical supplies. Drone deliveries are a technology being explored broadly, but they could mean significant improvements in the standard of care at hospitals and other treatment facilities.
Another big potential innovation in the coming years is a stem-cell treatment for diabetes. Although there are no approved therapies as of yet, work in this field has been ongoing for over a decade. The development of a device or therapy of this nature could be groundbreaking and has attracted the eye of many institutional investors.
